Goldman Sachs Decreases Price Target On Walgreen To $47

According to Goldman Sachs, Walgreen WAG price target is decreased to $47. Goldman Sachs said that WAG's underlying May quarter results exceeded our expectation, with EBIT beating our forecast in high-quality fashion, as gross margin rate exceeded our estimate despite input cost pressures, offset in part by higher SG&A, which we view as discretionary in the context of better gross profit dollars. “We trim our 12-month price target by $1, to $47. Our price target is based on risk/reward (P/E) and DCF but now incorporates a 25% probability that the conflict with ESRX is not resolved, resulting in a 6% reduction in WAG EPS; this scenario drives our price target lower.” Walgreen closed yesterday at $43.28.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorAnalyst RatingsConsumer StaplesDrug RetailGoldman SachsWalgreen Co.
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!